Primary sclerosing cholangitis: diagnostic and management challenges

References

• ChapmanRFeveryJKallooADiagnosis and management of primary sclerosing cholangitisHepatology2009512660678
   Web of Science ®Google Scholar
• LindorKKowdleyKHarrisonMACG clinical guideline: primary sclerosing cholangitisAm J Gastroenterol2015110564665925869391
   PubMed Web of Science ®Google Scholar
• ReaDJHeimbachJKRosenCBLiver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinomaAnn Surg2005242345146116135931
   PubMed Web of Science ®Google Scholar
• LeeYKaplanMPrimary sclerosing cholangitisN Engl J Med1995332149249337877651
   PubMed Web of Science ®Google Scholar
• AnguloPLindorKPrimary sclerosing cholangitisHepatology199930132533210385674
   PubMed Web of Science ®Google Scholar
• LindorKNew treatment strategies for primary sclerosing cholangitisDig Dis201129111311621691116
   PubMed Web of Science ®Google Scholar
• PonsioenCNatural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch populationGut200251456256612235081
   PubMed Web of Science ®Google Scholar
• TalwalkarJLindorKNatural history and prognostic models in primary sclerosing cholangitisBest Pract Res Clin Gastroenterol200115456357511492968
   PubMed Web of Science ®Google Scholar
• HoussetCUpdates on primary sclerosing cholangitisCurr Opin Gastroenterol2017332697028079751
   PubMed Web of Science ®Google Scholar
• LernerAJeremiasPMatthiasTThe world incidence and prevalence of autoimmune diseases is increasingInt J Celiac Dis201634151155
   Google Scholar
• GotthardtDChahoudFSauerPPrimary sclerosing cholangitis: diagnostic and therapeutic problemsDig Dis201129s1414522104752
   PubMed Web of Science ®Google Scholar
• BobergKChapmanRHirschfieldGLohseAMannsMSchrumpfEOverlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issueJ Hepatol201154237438521067838
   PubMed Web of Science ®Google Scholar
• PollockGMinukGDiagnostic considerations for cholestatic liver diseaseJ Gastroenterol Hepatol20173271303130928106928
   PubMed Web of Science ®Google Scholar
• AnguloPPeterJGershwinMSerum autoantibodies in patients with primary sclerosing cholangitisJ Hepatol200032218218710707856
   PubMed Web of Science ®Google Scholar
• MendesFJorgensenRKeachJElevated serum IgG4 concentration in patients with primary sclerosing cholangitisAm J Gastroenterol200610192070207516879434
   PubMed Web of Science ®Google Scholar
• HiranoKKawabeTYamamotoNSerum IgG4 concentrations in pancreatic and biliary diseasesClinica Chimica Acta20063671–2181184
   Web of Science ®Google Scholar
• WallaceZDeshpandeVMattooHIgG4-related disease: clinical and laboratory features in one hundred twenty-five patientsArthritis Rheumatol20156792466247525988916
   PubMed Web of Science ®Google Scholar
• DaveMElmunzerBDwamenaBHigginsPPrimary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatographyRadiology2010256238739620656832
   PubMed Web of Science ®Google Scholar
• SaidKGlaumannHBergquistAGallbladder disease in patients with primary sclerosing cholangitisJ Hepatol200848459860518222013
   PubMed Web of Science ®Google Scholar
• BucklesDLindorKLaRussoNPetrovicLGoresGIn primary sclerosing cholangitis, gallbladder polyps are frequently malignantAm J Gastroenterol20029751138114212014717
   PubMed Web of Science ®Google Scholar
• WeeALudwigAPericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?Ann Intern Med198510255813985511
   PubMed Web of Science ®Google Scholar
• BrooméUGlaumannHLindstömENatural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)J Hepatol200236558658911983440
   PubMed Web of Science ®Google Scholar
• AnguloPMaor-KendlerYLindorKSmall-duct primary sclerosing cholangitis: a long-term follow-up studyHepatology20023561494150012029635
   PubMed Web of Science ®Google Scholar
• BjörnssonEOlssonRBergquistAThe natural history of small-duct primary sclerosing cholangitisGastroenterology2008134497598018395078
   PubMed Web of Science ®Google Scholar
• BjornssonEPatients with small duct primary sclerosing cholangitis have a favourable long term prognosisGut200251573173512377815
   PubMed Web of Science ®Google Scholar
• BurakKAnguloPLindorKIs there a role for liver biopsy in primary sclerosing cholangitis?Am J Gastroenterol20039851155115812809842
   PubMed Web of Science ®Google Scholar
• LudwigJBarhamSLarussoNElvebackLWiesnerRMcCallJMorphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitisHepatology1981166326407308996
   PubMedGoogle Scholar
• CorpechotCEl NaggarAPoujol-RobertAAssessment of biliary fibrosis by transient elastography in patients with PBC and PSCHepatology20064351118112416628644
   PubMed Web of Science ®Google Scholar
• EatonJDzyubakBVenkateshSPerformance of magnetic resonance elastography in primary sclerosing cholangitisJ Gastroenterol Hepatol20163161184119026691631
   PubMed Web of Science ®Google Scholar
• FausaOSchrumpfEElgjoKRelationship of inflammatory bowel disease and primary sclerosing cholangitisSemin Liver Dis1991110131392047887
   PubMed Web of Science ®Google Scholar
• PalmerKDuerdenBHoldsworthCBacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgeryGut198021108518547439804
   PubMed Web of Science ®Google Scholar
• VinnikIEKernFJrStruthersJEJrHillRBGuzakSExperimental chronic portal vein bacteremiaProc Soc Exp Biol Med1964115231131414121596
   PubMed Web of Science ®Google Scholar
• LichtmanSSartorRKekuJSchwabJHepatic inflammation in rats with experimental small intestinal bacterial overgrowthGastroenterology19909824144232295397
   PubMed Web of Science ®Google Scholar
• WoolfGVierlingJDisappearing intrahepatic bile ducts: the syndromes and their mechanismsSemin Liver Dis199313032612758235716
   PubMed Web of Science ®Google Scholar
• WellgeBSterneckMTeufelAPregnancy in primary sclerosing cholangitisGut20116081117112121339205
   PubMed Web of Science ®Google Scholar
• EatonJTalwalkarJLazaridisKGoresGLindorKPathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementGastroenterology2013145352153623827861
   PubMed Web of Science ®Google Scholar
• LindströmLHultcrantzRBobergKFriis–LibyIBergquistAAssociation between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitisClin Gastroenterol Hepatol201311784184623353641
   PubMed Web of Science ®Google Scholar
• PaumgartnerGUrsodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisitedHepatology200236352553112198643
   PubMed Web of Science ®Google Scholar
• ChenWGluudCBile acids for primary sclerosing cholangitis (A Cochrane systematic review)J Hepatol200338205
   Web of Science ®Google Scholar
• CharatcharoenwitthayaPAnguloPEndersFLindorKImpact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitisHepatology2007471133142
   Web of Science ®Google Scholar
• StiehlAWalkerSStiehlLRudolphGHofmannWTheilmannLEffect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodJ Hepatol199420157648201224
   PubMed Web of Science ®Google Scholar
• HarnoisDHigh dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitisYear Bk Gastroenterol20102010240241
   Google Scholar
• ChapmanRMedical treatment of primary sclerosing cholangitis with ursodeoxycholic acidDig Liver Dis200335530630812846401
   PubMedGoogle Scholar
• Van HoogstratenHWolfhagenFvan de MeebergPUrsodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily dosesJ Hepatol19982934174239764988
   PubMed Web of Science ®Google Scholar
• StiehlARudolphGSauerPEfficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitisJ Hepatol19972635605669075663
   PubMed Web of Science ®Google Scholar
• ShiJLiZZengXLinYXieWUrsodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trialsHepatol Res200939986587319467021
   PubMed Web of Science ®Google Scholar
• WunschETrottierJMilkiewiczMProspective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitisHepatology201460393194024519384
   PubMed Web of Science ®Google Scholar
• TabibianJLindorKUrsodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?)Hepatology201460378578824752961
   PubMed Web of Science ®Google Scholar
• FickertPWagnerMMarschallH24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout miceGastroenterology2006130246548116472600
   PubMed Web of Science ®Google Scholar
• AnguloPOral budesonide in the treatment of primary sclerosing cholangitisAm J Gastroenterol20009592333233711007238
   PubMed Web of Science ®Google Scholar
• KochharRGoenkaMDasKPrimary sclerosing cholangitis: an experience from IndiaJ Gastroenterol Hepatol19961154294338743914
   PubMed Web of Science ®Google Scholar
• HayJThe metabolic bone disease of primary sclerosing cholangitisHepatology19911422572611860683
   PubMed Web of Science ®Google Scholar
• WiesnerRLudwigJLindorKA controlled trial of cyclosporine in the treatment of primary biliary cirrhosisN Eng J Med19903222014191424
   PubMed Web of Science ®Google Scholar
• Van ThielDHCarrollPAbu-ElmagdKTacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trialAm J Gastroenterol1995904557532912
   PubMed Web of Science ®Google Scholar
• KaplanMMAroraSPincusSHPrimary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic responseAnn Intern Med19871062312948435
   PubMed Web of Science ®Google Scholar
• KnoxTAKaplanMMTreatment of primary sclerosing cholangitis with oral methotrexateAm J Gastroenterol1991865462028943
   PubMed Web of Science ®Google Scholar
• KnoxTAKaplanMMA double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitisGastroenterology19941064948299916
   PubMed Web of Science ®Google Scholar
• LindorKDJorgensenRAAndersonMLUrsodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot studyAm J Gastroenterol1996915118633500
   PubMed Web of Science ®Google Scholar
• JavettSLAzathioprine in primary sclerosing cholangitifLancet19711810
   PubMed Web of Science ®Google Scholar
• WagnerAAzathioprine treatment in primary sclerosing cholangitisLancet19712663
   PubMed Web of Science ®Google Scholar
• KaplanMMMedical approaches to primary sclerosing cholangitisSemin Liver Dis199111562047891
   PubMed Web of Science ®Google Scholar
• GrossJBJrLudwigJWiesnerRHAbnormalities in tests of copper metabolism in primary sclerosing cholangitisGastroenterology1985892724007418
   PubMed Web of Science ®Google Scholar
• LaRussoNFWiesnerRHLudwigJProspective trial of penicillamine in primary sclerosing cholangitisGastroenterology19889510363410217
   PubMed Web of Science ®Google Scholar
• KowdleyKVKnoxTAKaplanMMHepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitisDig Dis Sci19943924167956610
   PubMed Web of Science ®Google Scholar
• EpsteinMPKaplanMMA pilot study of etanercept in the treatment of primary sclerosing cholangitisDig Dis Sci200449114992426
   PubMed Web of Science ®Google Scholar
• HommesDWErkelensWPonsioenCA double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitisJ Clin Gastroenterol20084252218344886
   PubMed Web of Science ®Google Scholar
• LichtmanSNSartorRBKekuJSchwabJHHepatic inflammation in rats with experimental small intestinal bacterial overgrowthGastroenterology1990984142295397
   PubMed Web of Science ®Google Scholar
• FärkkiläMKarvonenALNurmiHMetronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trialHepatology200440137915565569
   PubMed Web of Science ®Google Scholar
• DaviesYKCoxKMAbdullahBALong-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibioticJ Pediatr Gastroenterol Nutr2008476118607270
   PubMed Web of Science ®Google Scholar
• SilveiraMGTorokNJGossardAAMinocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot studyAm J Gastroenterol20091048319098854
   PubMed Web of Science ®Google Scholar
• TabibianJHWeedingEJorgensenRARandomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis – a pilot studyAliment Pharmacol Ther20133760423384404
   PubMed Web of Science ®Google Scholar
• MacCartyRLLaRussoNFWiesnerRHLudwigJPrimary sclerosing cholangitis: findings on cholangiography and pancreatographyRadiology1983149396412283
   PubMed Web of Science ®Google Scholar
• MayGRBenderCELaRussoNFWiesnerRHNonoperative dilatation of dominant strictures in primary sclerosing cholangitisAJR Am J Roentgenol198514510613876737
   PubMed Web of Science ®Google Scholar
• StiehlARudolphGKlöters-PlachkyPDevelopment of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatmentJ Hepatol20023615111830325
   PubMed Web of Science ®Google Scholar
• BjörnssonELindqvist-OttossonJAsztelyMOlssonRDominant strictures in patients with primary sclerosing cholangitisAm J Gastroenterol20049950215056092
   PubMed Web of Science ®Google Scholar
• EckhauserFEColletiLMKnolJAThe changing role of surgery for sclerosing cholangitisDig Dis1996141808861525
   PubMed Web of Science ®Google Scholar
• CameronJLPittHAZinnerMJResection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitisAnn Surg19882076143377571
   PubMed Web of Science ®Google Scholar
• GoldenringJRCahowCEIntrahepatic cholangiojejunostomy as a palliative procedure in primary sclerosing cholangitisArch Surg19891245652469409
   PubMedGoogle Scholar
• MyburghJASurgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approachArch Surg199412910577944935
   PubMedGoogle Scholar
• FargesOMalassagneBSebaghMBismuthHPrimary sclerosing cholangitis: liver transplantation or biliary surgerySurgery19951171467846618
   PubMed Web of Science ®Google Scholar
• PawlikTMOlbrechtVAPittHAPrimary sclerosing cholangitis: role of extrahepatic biliary resectionJ Am Coll Surg200820682218471705
   PubMed Web of Science ®Google Scholar
• CangemiJRWiesnerRHBeaverSJEffect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitisGastroenterology19899637907942914641
   PubMed Web of Science ®Google Scholar
• LangnasANGraziGLStrattaRJPrimary sclerosing cholangitis: the emerging role for liver transplantationAm J Gastroenterol19908511362167607
   PubMed Web of Science ®Google Scholar
• McEnteeGWiesnerRHRosenCA comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosisTransplant Proc19912315631989291
   PubMed Web of Science ®Google Scholar
• GraziadeiIWWiesnerRHMarottaPJLong-term results of patients undergoing liver transplantation for primary sclerosing cholangitisHepatology199930112110534330
   PubMed Web of Science ®Google Scholar
• DicksonERMurtaughPAWiesnerRHPrimary sclerosing cholangitis: refinement and validation of survival modelsGastroenterology199210318931451982
   PubMed Web of Science ®Google Scholar
• FickertPWagnerMMarschallHU24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout miceGastroenterology200613046548116472600
   PubMed Web of Science ®Google Scholar
• HalilbasicEFiorottoRFickertPSide chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− miceHepatology2009491972198119475687
   PubMed Web of Science ®Google Scholar
• O ChazouilleresCCGaouarFPouponRFenofibrate improves liver tests in primary sclerosing cholangitis with incomplete biochemical response to ursodeoxycholic acidHepatology201052488A
   Web of Science ®Google Scholar
• NakamutaMFujinoTYadaRTherapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathwayInt J Clin Pharmacol Ther201048222820040336
   PubMed Web of Science ®Google Scholar